Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis
about
Role of fatty acid de novo biosynthesis in polyhydroxyalkanoic acid (PHA) and rhamnolipid synthesis by pseudomonads: establishment of the transacylase (PhaG)-mediated pathway for PHA biosynthesis in Escherichia coliEpidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubsInhibiting N-acyl-homoserine lactone synthesis and quenching Pseudomonas quinolone quorum sensing to attenuate virulenceTriclosan Derivatives: Towards Potent Inhibitors of Drug-Sensitive and Drug-ResistantMycobacterium tuberculosisDual-resolution molecular dynamics simulation of antimicrobials in biomembranesAntibacterial household products: cause for concernCharacterization of molecular mechanisms controlling fabAB transcription in Pseudomonas aeruginosaHigh-level pacidamycin resistance in Pseudomonas aeruginosa is mediated by an opp oligopeptide permease encoded by the opp-fabI operonTriclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductaseThe MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosanFatty acid biosynthesis in Pseudomonas aeruginosa is initiated by the FabY class of β-ketoacyl acyl carrier protein synthasesCharacterization of a Pseudomonas aeruginosa fatty acid biosynthetic gene cluster: purification of acyl carrier protein (ACP) and malonyl-coenzyme A:ACP transacylase (FabD)The fitness burden imposed by synthesising quorum sensing signals.A probable aculeacin A acylase from the Ralstonia solanacearum GMI1000 is N-acyl-homoserine lactone acylase with quorum-quenching activity.Interference with Pseudomonas quinolone signal synthesis inhibits virulence factor expression by Pseudomonas aeruginosa.Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ.Genes encoding the N-acyl homoserine lactone-degrading enzyme are widespread in many subspecies of Bacillus thuringiensis.Discovery of a novel and potent class of FabI-directed antibacterial agentsComparative systems biology analysis to study the mode of action of the isothiocyanate compound Iberin on Pseudomonas aeruginosa.Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistanceSynergistic effect of 14-alpha-lipoyl andrographolide and various antibiotics on the formation of biofilms and production of exopolysaccharide and pyocyanin by Pseudomonas aeruginosa.A novel role for an ECF sigma factor in fatty acid biosynthesis and membrane fluidity in Pseudomonas aeruginosaIdentification and characterization of a GDSL esterase gene located proximal to the swr quorum-sensing system of Serratia liquefaciens MG1Fatty acid biosynthesis as a target for novel antibacterialsIdentification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteinsVirulence and prodigiosin antibiotic biosynthesis in Serratia are regulated pleiotropically by the GGDEF/EAL domain protein, PigX.Effects of 14-alpha-lipoyl andrographolide on quorum sensing in Pseudomonas aeruginosa.Exploiting quorum sensing to confuse bacterial pathogens.Quorum-quenching microbial infections: mechanisms and implicationsIn Search of Alternative Antibiotic Drugs: Quorum-Quenching Activity in Sponges and their Bacterial Isolates.Development of quorum-based anti-virulence therapeutics targeting Gram-negative bacterial pathogens.Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.Choosing an appropriate infection model to study quorum sensing inhibition in Pseudomonas infections.Crystallization and preliminary X-ray crystallographic studies of enoyl-acyl carrier protein reductase (FabI) from Psuedomonas aeruginosa.Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis.Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target.Epigallocatechin Gallate Remodels Overexpressed Functional Amyloids in Pseudomonas aeruginosa and Increases Biofilm Susceptibility to Antibiotic Treatment.Toxicogenomic response of Rhodospirillum rubrum S1H to the micropollutant triclosanFunctional Characterization of Triclosan-Resistant Enoyl-acyl-carrier Protein Reductase (FabV) in Pseudomonas aeruginosa.In vivo target exploration of apidaecin based on Acquired Resistance induced by Gene Overexpression (ARGO assay)
P2860
Q24549917-A40BD001-8950-4626-9D89-95313D7FE581Q24562996-6CC64F97-FE3C-4B42-B60A-3BF9182EFE33Q26779425-65CB76D5-00E2-457C-B2BB-A99CD6E43DCCQ27653366-36A2A8FE-B141-4B59-9B22-C014A9C8F6A3Q28299896-CFC34A3F-BED2-4FBD-9362-F947D7DB453DQ28345263-46DB1BA3-936E-48B8-937F-1DB6656E7ED7Q28484176-13B80D58-76B7-46DE-AD9B-7A503870A37BQ28492727-A3F4ED51-0E10-48B6-9387-97DBB29C4650Q28492833-A2270B74-0338-436A-8C4D-FDA85647C9CEQ28492850-AFFC199F-556F-4FE8-918C-1E739BBD0B06Q28493145-A83FAA1D-3DA4-40F9-9A80-F9E5032ED2F1Q28493242-4C0DD519-C3BB-4BBB-A96A-F9F2B94CD4B6Q30374337-F7D0A65F-19D9-41FE-AE15-20503F81B9ECQ33442093-101B9D37-A5C3-4E8F-8B0F-D72CDC9562F1Q33944784-67A93B1B-950C-4B88-B2B3-8CE338964C22Q33981336-D9E6E666-FFF4-47C7-92D2-9998972C3409Q34056316-2FF03767-3466-4ADA-8AC7-593A016EBB1AQ34143489-98A9A321-26BF-40F1-9F2E-74C84046FAD5Q34596938-4658B8DD-228D-4A70-95C7-DDDDB7596770Q34927172-BF0E646C-C3D4-4720-9C51-A2C074E4605DQ35004860-A3AB383C-9136-4918-9198-01F55BEEA4FAQ35081045-35B49A41-79B5-4562-8BA9-40AE0672D353Q35154044-DFAC28A6-95BC-4E9E-90C6-67DA9FB16E3BQ35713880-C1A805CF-D51E-4F35-85CC-29FF6D0F8115Q36314900-FB0AD3EC-1C33-4FBD-9E1B-9911CCBCCED1Q36314952-E4E6FC5B-697E-4CDF-BF31-D28487EA46E7Q36396230-DEE4C5B0-4FE8-4B16-A439-086CCF217075Q36667376-41BABF72-E365-4B5C-8C87-28DCA078ABB1Q36732544-A6E678D1-D37D-4B82-80D0-09EEB289499EQ36766012-00856796-A34C-4AF8-B17B-561F3744688DQ37139191-F6BE472E-AB56-4B31-B9B0-4413B84F1187Q37358382-2FE3B385-16BD-4D1E-B3AD-CD86FF4A3409Q38142717-8206BC86-BE4A-42C0-A01D-31D57B8D06F4Q38477356-51517EEA-DBEE-4806-935C-0F77F32BC3F2Q39654445-82B8A204-2E1D-42CE-8E2A-1B2B3C44CBC6Q40156598-F528CA55-F025-4EE8-B2DD-B7748EFC27DAQ40482939-A3CE7F32-FBE5-4644-A0DD-EE139BA8D752Q40752382-4F0A954D-AC85-453C-8840-F39FC19838F5Q42362561-AE5B4A2A-390F-49A3-8D14-639EEED0A6E9Q42362914-A9C712C7-3CF0-4B59-AB70-E6C9F2A21268
P2860
Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis
description
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im September 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/09/01)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/09/01)
@nl
наукова стаття, опублікована у вересні 1999
@uk
مقالة علمية (نشرت في سبتمبر 1999)
@ar
name
Characterization of Pseudomona ...... d homoserine lactone synthesis
@ast
Characterization of Pseudomona ...... d homoserine lactone synthesis
@en
Characterization of Pseudomona ...... d homoserine lactone synthesis
@nl
type
label
Characterization of Pseudomona ...... d homoserine lactone synthesis
@ast
Characterization of Pseudomona ...... d homoserine lactone synthesis
@en
Characterization of Pseudomona ...... d homoserine lactone synthesis
@nl
prefLabel
Characterization of Pseudomona ...... d homoserine lactone synthesis
@ast
Characterization of Pseudomona ...... d homoserine lactone synthesis
@en
Characterization of Pseudomona ...... d homoserine lactone synthesis
@nl
P2860
P3181
P1476
Characterization of Pseudomona ...... d homoserine lactone synthesis
@en
P2093
H. P. Schweizer
T. T. Hoang
P2860
P304
P3181
P407
P577
1999-09-01T00:00:00Z